Navigation Links
Bio/Data Corporation Launches vW Select(TM) - The World's First and Only Complete Ristocetin CoFactor Assay
Date:6/30/2009

vW Select Significantly Reduces Laboratory Variability and Provides Clinicians with More Reliable Test Results

HORSHAM, Pa., June 30 /PRNewswire/ -- Today, Bio/Data Corporation announced the launch of vW Select(TM), the world's first all-in-one Ristocetin CoFactor Assay. vW Select is the first and only complete assay that measures the functional activity of the von Willebrand Factor. A deficiency of von Willebrand Factor causes von Willebrand Disease -- the world's most common bleeding disorder.

This new assay system includes all the reagents, control plasma, reference plasma, and diluents required to construct a standard reference curve and determine the Ristocetin Cofactor Activity in patient samples. Assay components are formulated, optimized and performance tested as a system to assure that linear standard reference curves are easy to achieve and test results are consistent, reliable and available quickly.

vW Select is manufactured, validated and performance tested under USFDA Quality System Regulations as well as the ISO 13485:2003 (Medical Device) Quality Management System Standard. This simplifies test Implementation and CLIA compliance, while eliminating the onerous regulatory mandates for homebrew or lab developed tests.

The analytical variability of existing Ristocetin Cofactor test systems is high -- 30%, and inter laboratory variability is about the same. Random combinations of Ristocetin reagents, general purpose control and reference plasmas, buffers and diluents are primary contributors to these variabilities. The matched components in each vW Select kit have been selected, tested and optimized to meet current published guidelines by improving overall assay system performance and reducing analytical variability.

vW Select addresses the clinical laboratory's need for a complete, accurate and cost effective test system for the detection, diagnosis and management of von Willebrand Disease.

For a limited time, Bio/Data Corporation is offering free samples of vW Select to qualified laboratories. Submit an online request for a free sample at www.biodatacorp.com, or contact Customer Service at Bio/Data Corporation.

vW Select is CE marked and is available worldwide from Bio/Data Corporation and its authorized distributors.

For 40 years, Bio/Data Corporation has been a leading manufacturer and worldwide distributor of products for clinical and research laboratories. Bio/Data Corporation is an ISO 9001:2000 and 13485:2003 registered company.

    FOR MORE INFORMATION PLEASE CONTACT:
    Kay Callahan
    Bio/Data Corporation
    215-441-4000
    1-800-257-3282
    215-443-8820 Fax
    www.biodatacorp.com


'/>"/>
SOURCE Bio/Data Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Environmental Tectonics Corporations BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting
2. Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan
3. Environmental Tectonics Corporation Announces Additional Hyperbaric Monoplace Chamber Sale to St. John Wound Center
4. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
5. Guy J. Quigley Resigns as Chairman and CEO of The Quigley Corporation: Quigley Leaves Company He Founded 20 Years Ago
6. Techne Corporation Board Member Recognized
7. Mach One Corporation Developing a Nasal, Hand Carried Product as Solution to Swine Flu (H1N1) Virus
8. Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
9. Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
10. Techne Corporation Announces That John L. Higgins has Accepted a Seat on Technes Board
11. Onyx Pharmaceuticals Files Complaint Against Bayer Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Chapel Hill, N.C. (PRWEB) , ... June 27, ... ... of U.S. commercial operations for Amgen, will join the faculty of the ... will serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with ...
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
(Date:6/21/2016)... British Columbia , June 21, 2016 /PRNewswire/ ... appointed to the new role of principal product ... been named the director of customer development. Both ... NuData,s chief technical officer. The moves reflect NuData,s ... teams in response to high customer demand and ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
Breaking Biology News(10 mins):